5 Key Takeaways

• 1

  A new proteomic risk score based on 32 blood proteins may predict chronic obstructive pulmonary disease (COPD) risk and respiratory-related mortality.

• 2

  The study analyzed longitudinal data from 2,470 U.S. adults over 30 years as part of the CARDIA study.

• 3

  Participants with higher proteomic risk scores had an 84% increased likelihood of developing COPD and an 81% increased risk of respiratory-related mortality.

• 4

  The score was validated in two external cohorts, the UK Biobank and COPDGene, confirming its predictive utility for respiratory disease.

• 5

  The blood test requires further clinical trials before potential approval by the U.S. Food and Drug Administration as a screening tool.